The Uzbek Agency for the Development of the Pharmaceutical Industry and project developer Yangi Osiyo Biofarmatsevtika discussed progress on building a blood plasma medicine manufacturing plant in the Samarqand region. Discussions focused on schedule adherence and quality assurance, including technical support from specialists from the People's Republic of China.
The Uzbek Agency for the Development of the Pharmaceutical Industry and project developer Yangi Osiyo Biofarmatsevtika discussed progress on building a blood plasma medicine manufacturing plant in the Samarqand region. Discussions focused on schedule adherence and quality assurance, including technical support from specialists from the People's Republic of China.
Uzbekistan plans to modernize its blood supply system by 2030. Investments of 1.75 trillion sum are allocated until 2030. A new production facility for plasma products is planned.
AETEK® is a registered word mark of AETEK GmbH, German Patent and Trade Mark Office (DPMA), Reg. No. 30 2023 202 928 (expires 31 Jan. 2033).
View registration certificate (PDF)
Legal Entity Identifier (LEI) 391200MNLJ2E0R0I6V98, issued 16 Aug. 2021 by Bundesanzeiger Verlag.
View in GLEIF register
AETEK company flyer 2026 – Business Development as a Service, in English.
View flyer
AETEK Business Model Disclosure (pre-NDA, one page, October 2026), in English.
Download PDF